Abstract
Infective endocarditis (IE) is a life-threatening disease associated with high mortality. Conventional microbiologic diagnosis is based mainly on culture-dependent methods that often fail because of previous antibiotic therapy or the involvement of fastidious or slowly growing microorganisms. In recent years, molecular techniques entered the field of routine diagnostics. Amplification-based methods proved useful for detection of microorganisms in heart valve tissue. More recently, they were applied to blood samples from patients with IE. Direct detection of microorganisms in valve specimens by fluorescence in situ hybridization allowed identification of the causative agent and simultaneous visualization of complex microbial communities. These techniques will gain more importance in the near future, provided that procedures are standardized and results are interpreted with caution. With this review, we intend to give an overview of the impact and limitations of molecular techniques for the diagnosis of IE, including a focus on recent developments.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •Of importance ••Of major importance
Moreillon P, Que Y-A: Infective endocarditis. Lancet 2004, 363:139–149.
Hill EE, Herijgers P, Claus P, et al.: Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 2007, 28:196–203.
Tleyjeh IM, Abdel-Latif A, Rahbi H, et al.: A systematic review of population-based studies of infective endocarditis. Chest 2007, 132:1025–1035.
Friedman ND, Kaye KS, Stout JE, et al.: Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791–797.
•• Habib G, Hoen B, Tornos P, et al.: Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009, 30:2369–2413. This article includes the updated guidelines of the ESC that provide actual and comprehensive information about the relevant clinical aspects of infective endocarditis.
Wilson W, Taubert KA, Gewitz M, et al.: Prevention of infective endocarditis: guidelines from the american heart association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007, 116:1736–1754.
Nishimura RA, Carabello BA, Faxon DP, et al.: ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008, 118:887–896.
Bonow RO, Carabello BA, Chatterjee K, et al.: 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 52:e1–e142.
Prendergast BD: The changing face of infective endocarditis. Heart 2006, 92:879–885.
Fournier PE, Casalta JP, Habib G, et al.: Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med 1996, 100:629–633.
Li JS, Sexton DJ, Mick N, et al.: Proposed modifications to the Duke Criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633–638.
• Brouqui P, Raoult D: New insight into the diagnosis of fastidious bacterial endocarditis. FEMS Immunol Med Microbiol 2006, 47:1–13. This article provides a systematic review of diagnostic methods for detection of fastidious pathogens in BCNE.
Koegelenberg CF, Doubell AF, Orth H, Reuter H: Infective endocarditis: improving the diagnostic yield. Cardiovasc J S Afr 2004, 15:14–20.
Musci M, Weng Y, Hübler M, et al.: Homograft aortic root replacement in native or prosthetic active infective endocarditis: twenty-year single-center experience. J Thorac Cardiovasc Surg 2010, 139:665–673.
David TE, Gavra G, Feindel CM, et al.: Surgical treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg 2007, 133:144–149.
•• Madico GE, Rice PA: 16S-Ribosomal DNA to diagnose culture-negative endocarditis. Curr Infect Dis Rep 2008, 10:280–286. This article is a thorough review of the impact and challenges of molecular techniques targeting the 16S rDNA for microbiologic diagnosis of culture-negative endocarditis.
Houpikian P, Raoult D: Diagnostic methods. Current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis. Cardiol Clin 2003, 21:207–217.
Munoz P, Bouza E, Marin M, et al.: Heart valves should not routinely be cultured. J Clin Microbiol 2008, 49:2897–2901.
Raoult D, Casalta JP, Richet H, et al.: Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 2005, 43:5238–5242
Gouriet F, Samson L, Delaage M, et al.: Multiplex whole bacterial antigen microarray, a new format for the automation of serodiagnosis: the culture-negative endocarditis paradigm. Clin Microbiol Infect 2008, 14:1112–1118.
Millar B, Moore J, Mallon P, et al.: Molecular diagnosis of infective endocarditis: a new Duke’s Criterion. Scand J Infect Dis 2001, 33:673–680.
Gaibani P, Rossini G, Ambretti S, et al.: Blood culture systems: rapid detection—how and why? Int J Antimicrob Agents 2009, 34:S13–S15.
Casalta JP, Gouriet F, Roux V, et al.: Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnostic of infective endocarditis. Eur J Clin Microbiol Infect Dis 2009, 28:569–573.
Baty G, Lanotte P, Hocqueloux L, et al.: PCR rDNA 16S used for the etiological diagnosis of blood culture negative endocarditis [in French]. Med Mal Infect 2009 (Epub ahead of print).
Gauduchon V, Chalabreysse L, Etienne J, et al.: Molecular diagnosis of infective endocarditis by PCR amplification and direct sequencing of DNA from valve tissue. J Clin Microbiol 2003, 41:763–766.
Thuny F, Fournier PE, Casalta JP, et al.: Investigation of blood culture negative early prosthetic valve endocarditis reveals high prevalence of fungi. Heart 2009 (Epub ahead of print).
Breitkopf C, Hammel D, Scheld H, et al.: Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation 2005, 111:1415–1421.
Naber CK, Erbel R: Infective endocarditis with negative blood cultures. Int J Antimicrob Agents 2007, 30S:S32–S36.
Lang S, Watkin RW, Lambert PA, et al.: Detection of bacterial DNA in cardiac vegetations by PCR after the completion of antimicrobial treatment for endocarditis. Clin Microbiol Infect 2004, 10:579–581.
Rovery C, Greub G, Lepidi H, et al.: PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol 2005, 43:163–167.
Baddour LM, Wilson WR, Bayer AS, et al.: Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005, 111:e394–e434.
Nomura R, Nakano K, Nemoto H, et al.: Molecular analyses of bacterial DNA in extirpated heart valves from patients with infective endocarditis. Oral Microbiol Immunol 2009, 24:43–49.
Marin M, Munoz P, Sanchez M, et al.: Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine 2007, 86:195–202.
Vollmer T, Piper C, Horstkotte D, et al.: 23S rDNA real-time polymerase chain reaction of heart valves: a decisive tool in the diagnosis of infective endocarditis. Eur Heart J 2010 (Epub ahead of print).
Lepidi H, Coulibaly B, Casalta JP, Raoult D: Autoimmunohistochemistry: a new method for the histologic diagnosis of infective endocarditis. J Infect Dis 2006, 193:1711–1717.
Amann RI, Ludwig W, Schleifer KH: Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev 1995, 59:143–169.
Moter A, Göbel UB: Fluorescence in situ hybridization (FISH) for direct visualization of microorganisms. J Microbiol Methods 2000, 41:85–112.
Forrest GN, Roghmann MC, Toombs LS, et al.: Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 2008, 52:3558–3563.
Ly T, Gulia J, Pyrgos V, et al.: Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag 2008, 4:637–640.
Gescher DM, Kovacevic D, Schmiedel D, et al.: Fluorescence in situ hybridisation (FISH) accelerates identification of Gram-positive cocci in positive blood cultures. Int J Antimicrob Agents 2008, 32:S51–S59.
Wecke J, Kersten T, Madela K, et al.: A novel technique for monitoring the development of bacterial biofilms in human periodontal pockets. FEMS Microbiol Lett 2000, 191:95–101.
Mallmann C, Siemoneit S, Schmiedel D, et al.: Fluorescence in situ hybridization to improve the diagnosis of endocarditis: a pilot study. Clin Microbiol Infect 2009 (Epub ahead of print).
Gescher DM, Mallmann C, Kovacevic D, et al.: A view on Bartonella quintana endocarditis-confirming the molecular diagnosis by specific fluorescence in situ hybridization. Diagn Microbiol Infect Dis 2008, 60:99–103.
Goldenberger D, Künzli A, Vogt P, et al.: Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol 1997, 35:2733–2739.
Bosshard PP, Kronenberg A, Zbinden R, et al.: Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. Clin Infect Dis 2003, 37:167–172.
Podglajen I, Bellery F, Poyart C, et al.: Comparative molecular and microbiologic diagnosis of bacterial endocarditis. Emerg Infect Dis 2003, 9:1543–1547.
Lang S, Watkin RW, Lambert PA, et al.: Evaluation of PCR in the molecular diagnosis of endocarditis. J Infection 2004, 48:269–275.
Greub G, Lepidi H, Rovery C, et al.: Diagnosis of infectious endocarditis in patients undergoing valve surgery. Am J Med 2005, 118:230–238.
Kotilainen P, Heiro M, Jalava J, et al.: Aetiological diagnosis of infectious endocarditis by direct amplification of rRNA genes from surgically removed valve tissue. An 11-year experience in a Finnish teaching hospital. Ann Med 2006, 38:263–273.
Voldstedlund M, Pedersen LN, Baandrup U, et al.: Broad-range PCR and sequencing in routine diagnosis of infective endocarditis. APMIS 2008, 116:190–198.
Disclosure
No potential conflict of interest relevant to this article was reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moter, A., Musci, M. & Schmiedel, D. Molecular Methods for Diagnosis of Infective Endocarditis. Curr Infect Dis Rep 12, 244–252 (2010). https://doi.org/10.1007/s11908-010-0111-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11908-010-0111-6
Keywords
- Endocarditis
- Molecular diagnostics
- Blood culture
- Heart valves
- Fluorescence in situ hybridization
- PCR
- Culture-negative infectious endocarditis
- Duke classification
- Duke criteria
- Bloodstream infections
- 16S rRNA
- Amplification-based methods
- Autoimmunohistochemistry
- Serology
- Culture techniques
- Abiotrophia
- Brucella
- Bartonella
- Coxiella
- HACEK group
- Tropheryma whipplei